Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006930 |
---|---|
Receipt number | R000008188 |
Scientific Title | Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) study on anticoagulant therapy in nonvalvular atrial fibrillation (NVAF) |
Date of disclosure of the study information | 2011/12/22 |
Last modified on | 2020/12/15 11:01:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/12/21 20:40:14 | ||
2 | Update | 2011/12/22 13:50:26 | Institutions |
|
3 | Update | 2012/12/21 11:00:45 | Institutions |
|
4 | Update | 2013/02/09 15:32:40 | Institutions |
|
5 | Update | 2013/02/09 15:33:40 | Last follow-up date |
|
6 | Update | 2013/12/21 16:32:34 | Email |
|
7 | Update | 2014/06/22 14:58:56 | Last follow-up date |
|
8 | Update | 2015/02/24 16:47:25 | Recruitment status URL releasing protocol Publication of results URL related to results and publications |
|
9 | Update | 2015/02/24 16:52:31 | Results |
|
10 | Update | 2015/03/02 18:05:38 | Name of person sending information Name of person sending information Division name Division name |
|
11 | Update | 2018/06/26 09:45:30 | Name of primary person or sponsor Department Organization Category of Funding Organization |
|
12 | Update | 2018/06/26 09:59:49 | Recruitment status Anticipated trial start date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results Results |
|
13 | Update | 2019/03/12 12:56:44 | UMIN ID1 |
|
14 | Update | 2020/12/15 10:50:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Address Address TEL Tel1 Email1 Organization Organization Address Address Tel |
|
15 | Update | 2020/12/15 10:56:51 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
16 | Update | 2020/12/15 11:01:49 | Date of IRB |